Please login to the form below
EHA 2021
This page shows the latest EHA 2021 news and features for those working in and with pharma, biotech and healthcare.
J&J’s Darzalex shows ‘significant’ survival benefit in newly diagnosed multiple myeloma
Johnson &Johnson’s CD38 monoclonal antibody (mAb) Darzalex has achieved ‘significant’ overall survival (OS) data in newly diagnosed multiple myeloma, the company revealed at the European Hematology Association 2021 virtual congress ... EHA). The
Latest news
-
bluebird bio presents new data for beti-cel in beta thalassemia at EHA2021
bluebird bio has presented new data for its gene therapy betibeglogene autotemcel (beti-cel) at the European Hematology Association 2021 virtual congress (EHA) in transfusion dependent beta thalassemia (TDT). ... studies. As of 9 March 2021, 51 of 63 beti
-
Novartis’ iptacopan scores positive results in rare blood disorder PNH
According to the data, presented at the European Hematology Association 2021 virtual congress (EHA), treatment with 12 weeks of iptacopan was generally well tolerated and led to ‘rapid and durable’ ... 14th June 2021.
-
Roche reveals four-year follow-up data for Venclyxto in CLL at EHA2021
14th June 2021.
-
BMS, Acceleron’s Reblozyl shows new improvements for beta thalassemia patients
The data, presented at the EHA 2021 virtual congress, shows a 77% haemoglobin increase in patients treated with Reblozyl. ... The data, presented at the European Hematology Association (EHA) 2021 virtual congress, demonstrated that 77% of patients
More from news
Approximately 1 fully matching, plus 4 partially matching documents found.
Subscribe to our email news alerts
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Pfizer reports positive results for elranatamab in multiple myeloma
- BMS presents positive four-year results for Opdivo combination in lung cancer
- Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
- Pfizer’s antibiotic combination shows promise in treating multi-drug resistant infections
- AstraZeneca shares positive phase 3 results for Tagrisso in lung cancer
- Merck sues US government over Medicare drug price negotiation programme
- European Commission grants two new marketing authorisations for UCB's Bimzelx
- AstraZeneca/Sanofi’s RSV antibody backed by FDA advisory committee for infants
- Janssen shares positive phase 3 results for cilta-cel in multiple myeloma
- Parkinson’s disease: past, present and future
- How to Increase Engagement During Virtual Events
- AstraZeneca to stop post-marketing study of Andexxa following early success
No results were found
PMHub
Havas Lynx Group
We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...
Latest intelligence
- Parkinson’s disease: past, present and future
- Examining the history and complexities of Parkinson’s disease – one of the most prevalent neurodegenerative disorders that affects over 10 million people worldwide...
- The 17th World Congress on Controversies in Neurology
- This year, there was a focus on the rare disease neuromyelitis optica spectrum disorder that strikes suddenly and mainly impacts women...
- Archetypes: Rethinking go-to-market expectations to drive commercial success
- In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
